A detailed history of Acorn Wealth Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Acorn Wealth Advisors, LLC holds 572 shares of LLY stock, worth $474,611. This represents 0.27% of its overall portfolio holdings.

Number of Shares
572
Previous 566 1.06%
Holding current value
$474,611
Previous $440,000 17.5%
% of portfolio
0.27%
Previous 0.24%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$724.87 - $909.04 $4,349 - $5,454
6 Added 1.06%
572 $517,000
Q1 2024

Apr 26, 2024

BUY
$592.2 - $792.28 $592 - $792
1 Added 0.18%
566 $440,000
Q3 2023

Nov 07, 2023

BUY
$434.7 - $599.3 $49,121 - $67,720
113 Added 25.0%
565 $303,000
Q2 2023

Aug 02, 2023

BUY
$350.74 - $468.98 $158,534 - $211,978
452 New
452 $211,000
Q2 2018

Aug 10, 2018

SELL
$75.7 - $86.88 $3,179 - $3,648
-42 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$81.94 - $87.89 $3,441 - $3,691
42
42 $4,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $788B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Acorn Wealth Advisors, LLC Portfolio

Follow Acorn Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acorn Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acorn Wealth Advisors, LLC with notifications on news.